![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication March 5, 2004.
Revised June 9, 2004.
Accepted for publication July 2, 2004.
It is established that neuronal NO synthase (nNOS) is ubiquitinated and proteasomally degraded. The metabolism-based inactivation of nNOS as well as the inhibition of hsp90-based chaperones, which are known to regulate nNOS, both lead to enhanced proteasomal degradation of nNOS. The mechanism of this selective proteolytic degradation, or in essence how the nNOS becomes labilized and recognized for ubiquitination and subsequent degradation, has not been determined. In the current study, we used a crude preparation of reticulocyte proteins, which contains ubiquitin conjugating enzymes and the proteasome, to determine how nNOS is labilized. We found that the inactive monomeric heme-deficient apo-nNOS is rapidly degraded in vitro, consistent with the finding that both metabolism-based inactivation and inhibition of hsp90-based chaperones cause the formation of apo-nNOS and enhance its degradation in vivo. In the current study we discovered that destabilization of the dimeric nNOS, as determined by measuring the SDS-resistant dimer, is sufficient to trigger ubiquitin-proteasomal degradation. Treatment of nNOS with NG-nitro-L-arginine or 7-nitroindazole led to stabilization of the dimeric nNOS and decreased proteasomal degradation of the enzyme, consistent with that observed in cells. Thus, it appears that the dimeric structure is a major determinant of nNOS stability and proteolysis.
Key words:
Nitric oxide synthases, Regulation - post-transcriptional, Reactive intermediates
This article has been cited by other articles:
![]() |
V. Ruano-Rubio and M. A. Fares Testing the Neutral Fixation of Hetero-Oligomerism in the Archaeal Chaperonin CCT Mol. Biol. Evol., June 1, 2007; 24(6): 1384 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Carreras and J. J. Poderoso Mitochondrial nitric oxide in the signaling of cell integrated responses Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1569 - C1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Dunbar, G. J. Jenkins, S. Jianmongkol, M. Nakatsuka, E. R. Lowe, M. Lau, and Y. Osawa Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo Drug Metab. Dispos., September 1, 2006; 34(9): 1448 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Wood and D. Giroux Expression of Nitric Oxide Synthase Isoforms in the Ovine Fetal Brain: Alteration by Hormonal and Hemodynamic Stimuli Reproductive Sciences, July 1, 2006; 13(5): 329 - 337. [Abstract] [PDF] |
||||
![]() |
I. Ispolatov, A. Yuryev, I. Mazo, and S. Maslov Binding properties and evolution of homodimers in protein-protein interaction networks Nucleic Acids Res., June 27, 2005; 33(11): 3629 - 3635. [Abstract] [Full Text] [PDF] |
||||